LB
Therapeutic Areas
Tessellate BIO Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ALT program | Cancers with Alternative Lengthening of Telomeres (ALT) mechanism | Pre-clinical |
| Loss-of-Function (LoF) program | Cancers with Retinoblastoma 1 (RB1) Loss-of-Function | Pre-clinical |